Logo image of IBAB.BR

ION BEAM APPLICATIONS (IBAB.BR) Stock Overview

Europe - EBR:IBAB - BE0003766806 - Common Stock

11.58 EUR
-0.1 (-0.86%)
Last: 9/12/2025, 7:00:00 PM

IBAB.BR Key Statistics, Chart & Performance

Key Statistics
52 Week High15.14
52 Week Low9.4
Market Cap350.64M
Shares30.28M
Float18.86M
Yearly Dividend0.17
Dividend Yield1.45%
EPS(TTM)0.57
PE20.32
Fwd PE10.42
Earnings (Next)11-20 2025-11-20
IPO06-13 1998-06-13
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


IBAB.BR short term performance overview.The bars show the price performance of IBAB.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -2 -4 -6 -8

IBAB.BR long term performance overview.The bars show the price performance of IBAB.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10

The current stock price of IBAB.BR is 11.58 EUR. In the past month the price increased by 0.17%. In the past year, price decreased by -13.99%.

ION BEAM APPLICATIONS / IBAB Daily stock chart

IBAB.BR Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 26.63 194.17B
1ISRG.MI INTUITIVE SURGICAL INC 58.13 143.59B
IUI1.DE INTUITIVE SURGICAL INC 56.39 139.27B
BSX.DE BOSTON SCIENTIFIC CORP 36.53 130.99B
2M6.DE MEDTRONIC PLC 16.87 102.37B
SHL.DE SIEMENS HEALTHINEERS AG 20.01 53.72B
BOX.DE BECTON DICKINSON AND CO 13.28 46.49B
EWL.DE EDWARDS LIFESCIENCES CORP 30.48 39.37B
DC4.DE DEXCOM INC 44.92 25.55B
1DXCM.MI DEXCOM INC 45.45 25.13B
PHI1.DE KONINKLIJKE PHILIPS NV 16.83 23.34B
PHIA.AS KONINKLIJKE PHILIPS NV 16.69 23.15B

About IBAB.BR

Company Profile

IBAB logo image Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon and currently employs 2,118 full-time employees. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

Company Info

ION BEAM APPLICATIONS

Chemin du Cyclotron 3

Louvain-la-Neuve BRABANT-WALLON BE

Employees: 1943

IBAB Company Website

IBAB Investor Relations

Phone: 3210475811

ION BEAM APPLICATIONS / IBAB.BR FAQ

What is the stock price of ION BEAM APPLICATIONS today?

The current stock price of IBAB.BR is 11.58 EUR. The price decreased by -0.86% in the last trading session.


What is the ticker symbol for ION BEAM APPLICATIONS stock?

The exchange symbol of ION BEAM APPLICATIONS is IBAB and it is listed on the Euronext Brussels exchange.


On which exchange is IBAB.BR stock listed?

IBAB.BR stock is listed on the Euronext Brussels exchange.


What is the price forecast or stock price prediction for ION BEAM APPLICATIONS stock?

10 analysts have analysed IBAB.BR and the average price target is 15.81 EUR. This implies a price increase of 36.53% is expected in the next year compared to the current price of 11.58. Check the ION BEAM APPLICATIONS stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ION BEAM APPLICATIONS worth?

ION BEAM APPLICATIONS (IBAB.BR) has a market capitalization of 350.64M EUR. This makes IBAB.BR a Small Cap stock.


How many employees does ION BEAM APPLICATIONS have?

ION BEAM APPLICATIONS (IBAB.BR) currently has 1943 employees.


What are the support and resistance levels for ION BEAM APPLICATIONS (IBAB.BR) stock?

ION BEAM APPLICATIONS (IBAB.BR) has a support level at 11.39 and a resistance level at 11.76. Check the full technical report for a detailed analysis of IBAB.BR support and resistance levels.


Is ION BEAM APPLICATIONS (IBAB.BR) expected to grow?

The Revenue of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 16.35% in the next year. Check the estimates tab for more information on the IBAB.BR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ION BEAM APPLICATIONS (IBAB.BR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ION BEAM APPLICATIONS (IBAB.BR) stock pay dividends?

ION BEAM APPLICATIONS (IBAB.BR) has a dividend yield of 1.45%. The yearly dividend amount is currently 0.17. Check the full fundamental report for a detailed analysis of IBAB.BR dividend history, reliability and sustainability.


When does ION BEAM APPLICATIONS (IBAB.BR) report earnings?

ION BEAM APPLICATIONS (IBAB.BR) will report earnings on 2025-11-20.


What is the Price/Earnings (PE) ratio of ION BEAM APPLICATIONS (IBAB.BR)?

The PE ratio for ION BEAM APPLICATIONS (IBAB.BR) is 20.32. This is based on the reported non-GAAP earnings per share of 0.57 and the current share price of 11.58 EUR. Check the full fundamental report for a full analysis of the valuation metrics for IBAB.BR.


IBAB.BR Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to IBAB.BR. When comparing the yearly performance of all stocks, IBAB.BR is a bad performer in the overall market: 88.43% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

IBAB.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR. There are concerns on the financial health of IBAB.BR while its profitability can be described as average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IBAB.BR Financial Highlights

Over the last trailing twelve months IBAB.BR reported a non-GAAP Earnings per Share(EPS) of 0.57. The EPS increased by 110.64% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.86%
ROA 1.5%
ROE 8.34%
Debt/Equity 0.23
Chartmill High Growth Momentum
EPS Q2Q%74.97%
Sales Q2Q%47.69%
EPS 1Y (TTM)110.64%
Revenue 1Y (TTM)18.44%

IBAB.BR Forecast & Estimates

10 analysts have analysed IBAB.BR and the average price target is 15.81 EUR. This implies a price increase of 36.53% is expected in the next year compared to the current price of 11.58.

For the next year, analysts expect an EPS growth of 208.45% and a revenue growth 16.35% for IBAB.BR


Analysts
Analysts80
Price Target15.81 (36.53%)
EPS Next Y208.45%
Revenue Next Year16.35%

IBAB.BR Ownership

Ownership
Inst Owners25.71%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A